VLXVX vs XLE: 2% overlap
Vanguard Target Retirement 2065 and Energy Select Sector SPDR Fund share 1.6% of their portfolios by weight — computed as Σ min(wA, wB) over every holding both funds own.
Different holding dates. These holdings were published about 4 months apart — VLXVX as of 2026-03-31, the rest through 2026-07-23. Each fund is compared using its most recent file, so any trading in between shows up as a difference.
You would hold two tickers and get the diversification of 2.0. Two funds that shared nothing would score 2.0; two identical funds score 1.0.
Top shared holdings
VLXVX and XLE hold 22 of the same securities. The ten contributing most to the overlap figure:
| Holding | in VLXVX | in XLE | Δ |
|---|---|---|---|
| XOM | 0.4% | 20.8% | 20.4% |
| CVX | 0.2% | 15.1% | 14.9% |
| CASH | 2.0% | 0.1% | 1.9% |
| COP | 0.1% | 6.1% | 6.0% |
| WMB | 0.1% | 4.1% | 4.0% |
| VLO | 0.1% | 4.6% | 4.6% |
| MPC | 0.1% | 4.9% | 4.8% |
| SLB | 0.1% | 4.1% | 4.1% |
| EOG | 0.1% | 4.5% | 4.4% |
| PSX | 0.0% | 4.8% | 4.8% |
Where VLXVX and XLE differ
Sector weights as a share of each fund, ordered by the size of the gap rather than the size of the sector — two funds that overlap heavily still usually diverge somewhere.
| Sector | VLXVX | XLE | Δ |
|---|---|---|---|
| Energy | 2.8% | 99.8% | −97.0pp |
| Information Technology | 26.3% | 0.0% | +26.3pp |
| Financials | 14.1% | 0.0% | +14.1pp |
| Industrials | 10.6% | 0.0% | +10.6pp |
| Consumer Discretionary | 7.6% | 0.0% | +7.6pp |
| Health Care | 7.0% | 0.0% | +7.0pp |
| Unclassified | 6.1% | 0.0% | +6.1pp |
| Communication Services | 6.0% | 0.0% | +6.0pp |
Δ is VLXVX minus XLE, in percentage points. Sector data is not published by every issuer, so “Unclassified” is a real category rather than a gap in the table.
What each fund holds alone
96.6% of VLXVX by weight, held in no part of XLE.
0.0% of XLE by weight, held in no part of VLXVX.
A large count with a small weight is the usual shape: the positions one fund adds are typically its smallest ones.
Concentration and cost
| VLXVX | XLE | |
|---|---|---|
| Top 10 holdings | 19.3% | 73.1% |
| Positions held | 6 | 23 |
| Cost per $10,000 held, per year | $8 | $8 |
Cost is the expense ratio applied to $10,000; it excludes any brokerage commission, bid-ask spread or tax consequence. Figures are facts about the funds, not a suggestion about which to hold.
Frequently asked
How much do VLXVX and XLE overlap?
VLXVX and XLE overlap 1.6% by portfolio weight — largely distinct portfolios. They share 22 holdings. The figure comes from current issuer holdings files (VLXVX as of 2026-03-31, XLE as of 2026-07-23).
How is the overlap between VLXVX and XLE calculated?
As the sum of the smaller weight in each fund, over every holding both funds own: Σ min(wA, wB). If VLXVX holds a stock at 6% and XLE holds the same stock at 4%, 4% counts as shared. The result is bounded between 0% and 100%, and it is computed after looking through any fund-of-funds to the underlying holdings.
Is it redundant to hold both VLXVX and XLE?
That depends on your goals — we state facts, not advice. At 1.6% overlap, each fund still contributes meaningfully distinct exposure.
What does VLXVX own that XLE doesn't?
VLXVX holds 6 positions and XLE holds 23; 16,660 of VLXVX's positions don't appear in XLE at all, and they are 96.6% of VLXVX by weight.
You probably hold more than two funds
This page compares VLXVX and XLE. Paste your whole portfolio — brokerage, 401(k), IRA — and see the overlap across every fund at once, plus what you actually own underneath them and your own Effective Funds number. Free, no account, nothing stored.
X-ray my portfolio — free →Watch VLXVX vs XLE
We re-read both funds’ published holdings every weeknight. Leave an address and we'll tell you when what's inside actually changes.
Not sending yet — email alerts are built but switched off, and you'll be among the first when they turn on. No spam, one-click unsubscribe.
Related comparisons
Sources: issuer holdings files, VLXVX as of 2026-03-31, XLE as of 2026-07-23. Weights are fractions of each fund. Diagnostics, not advice.